Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences in September in New York:

H.C. Wainwright 26^th Annual Global Investment Conference (Lotte New York Palace Hotel)

September 9-11, 2024

Company will present at 8:00 a.m. ET on September 10, 2024

Lake Street 8th Annual Best Ideas Growth Conference – Big 8 (The Yale Club)

September 12, 2024

1x1 Meetings Only

Cantor 2024 Global Healthcare Conference (InterContinental New York Barclay Hotel)

September 17-19, 2024

Company will host a Fireside Chat at 2:30 p.m. ET on September 18, 2024

The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. To listen to the audio webcast of either the H.C. Wainwright or Cantor conferences, please visit the Company’s website. The Lake Street conference will not be webcast.

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240903179422/en/